Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nadine Abi-Jaoudeh

Vascular & Interventional Radiology Orange, CA Medical Doctor

NPI 1235337627 CMS profile 968001

101 The City Dr S, Orange, CA 92868

Open in the dashboard

General payments

$104,683

186 records reported · program years 2019–2025

Research payments

$2,084

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,160,753 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Nadine Abi-Jaoudeh of Orange, CA is reported in the CMS Open Payments database as having received $104,683 across 186 general payments and $2,084 in research payments paid to them. Separately, studies naming them as principal investigator received $1,160,753 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,680 55
2024 General $28,946 54
2023 General $19,604 19
2023 Research $2,084 2
2022 General $12,303 22
2021 General $9,401 14
2020 General $4,878 4
2019 General $1,870 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nadine Abi-Jaoudeh
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nadine Abi-Jaoudeh were reported at $27,680. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nadine Abi-Jaoudeh Vascular & Interventional Radiology median Middle half National median
2019 $1,870 $422 $125–$1,555 $163
2020 $4,878 $200 $68–$652 $114
2021 $9,401 $280 $99–$866 $132
2022 $12,303 $433 $137–$1,497 $149
2023 $19,604 $506 $152–$2,019 $160
2024 $28,946 $556 $175–$1,930 $164
2025 $27,680 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $22,672 43 payments
  2. Instylla Inc. $16,554 13 payments
  3. Sirtex Medical Inc $10,497 13 payments
  4. AstraZeneca Pharmaceuticals LP $10,317 12 payments
  5. Eisai Inc. $7,866 5 payments
  6. Genentech USA, Inc. $7,052 8 payments
  7. Medtronic, Inc. $4,415 21 payments
  8. Medical Device Business Services, Inc. $4,095 2 payments
  9. AngioDynamics, Inc. $3,231 4 payments
  10. Guerbet LLC $3,100 7 payments
  11. Other $14,884 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $66,384 38 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,850 7 payments
  3. Food and Beverage $12,400 118 payments
  4. Travel and Lodging $7,048 22 payments
  5. Honoraria $1,000 1 payment
Products named General payments · program years 2019–2025
  1. SIR-Spheres Microspheres $10,497 13 payments
  2. INSTYLLA DELIVERY KIT Vascular $8,714 5 payments
  3. INSTYLLA MICROCATHETER 1.2 $8,714 5 payments
  4. EMBRACE HYDROGEL EMBOLIC SYSTEM (HES) $8,714 5 payments
  5. IMFINZI $7,930 8 payments
  6. Lenvima $7,866 5 payments
  7. Instylla Delivery Kit Liquid Embolics for Interventional Radiology $6,903 5 payments
  8. General - Interventional Oncology $6,628 3 payments
  9. Certus 140 $6,620 7 payments
  10. INSTYLLA MICROCATHETER $5,500 3 payments
  11. Other $30,153 106 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. ABK Biomedical USA, Inc. $1,872 1 payment
  2. Medtronic, Inc. $213 1 payment

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$60,892

Medicare's payments for the services billed

Medicare patients

103

Average age 72

Services billed

622

41 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 49%
Arthritis 45%
Cancer 37%
Ischemic heart disease 31%
Chronic kidney disease 29%
Osteoporosis 25%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Lenvima
  • Eisai Inc. $2,400
$2,400 — —
TECENTRIQ
  • Genentech USA, Inc. $2,251
$2,251 — —
IMFINZI
  • AstraZeneca Pharmaceuticals LP $2,015
$2,015 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

188 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record